Clinical Research
corporate_fare

AlzeCure Pharma AB

Address
Halsovagen 7, Flemingsberg

Sponsor Overview

assignment
1
sponsored trial
science
0
molecules
location_city
1
research centre
public
1
country
person_search
1
investigator

Specializations

Neurodegenerative disease

Research activity includes Alzheimer’s disease, with a focus on cognitive impairment and related central nervous system targets relevant to memory and mental function.

  • Alzheimer’s disease
  • Cognitive dysfunction

The sponsor’s clinical work in this area reflects interest in therapies addressing disease mechanisms linked to decline in cognition and daily functioning.

Psychiatric disorders

Clinical interest extends to depression, indicating involvement in treatment areas where mood regulation and neurobiological pathways are central therapeutic concerns.

  • Depression
  • Central nervous system therapeutics

This domain aligns with broader research into interventions for affective symptoms and their impact on cognition and quality of life.

Neuroscience and cognition

The sponsor’s portfolio points to a strong emphasis on cognitive function, including symptoms that overlap across neurodegenerative and psychiatric conditions.

  • Cognitive function
  • Memory and attention

These interests suggest work centered on therapeutic strategies for preserving or improving brain performance in disorders with impaired thinking and behavior.

Early-stage clinical development

The sponsor is engaged in human clinical research in healthy participants, supporting investigation of novel neurotherapeutic candidates with relevance to brain disorders.

  • Healthy volunteer studies
  • Pharmacology of central nervous system agents

This area is closely tied to the assessment of emerging compounds intended for conditions affecting cognition, mood, and neurodegeneration.

Sponsored Trials

Trial Name Country Status
Phase Ib Randomized, Double-Blind, Placebo-Controlled Trial of ACD856 in Depression, Cognitive Dysfunction, and Alzheimer's DiseaseSweden SwedenNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 1 sites collaborated multiple times

This sponsor has worked with 1 site across their trial portfolio.

Therapeutic Focus

  • 1.
    Mental Disorders1 trial
    150 other sponsors
  • 2.
    Nervous System Diseases1 trial
    449 other sponsors

Partnered Research Centres

1 centre
location_city
assignment66
CTC Clinical Trial Consultants AB
Address
Dag Hammarskjolds Vag 10b, Uppsala Domkyrkofors., 752 37 Uppsala
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to AlzeCure Pharma AB.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.